Er. Matarredona et al., INVOLVEMENT OF IRON IN MPP-NIGRA - PROTECTION BY DESFERRIOXAMINE( TOXICITY IN SUBSTANTIA), Brain research, 773(1-2), 1997, pp. 76-81
Desferrioxamine (DES) protective effect against 1-methyl-4-phenylpyrid
inium (MPP+) toxicity was evaluated by microdialysis in the substantia
nigra. DES (1 mu M to 10 mM) co-perfused with MPP+ (2.5 mM) on day 1,
produced on day 2 a higher dopamine extracellular output after perfus
ion of MPP+ than in control-MPP+ perfusion experiments, in which no DE
S was administered on day 1. Both Ringer's perfusion alone (control-Ri
nger) and co-perfusion of DES (10 mM) with MPP+ (2.5 mM) on day 1 prod
uced on day 2 similar increases in dopamine extracellular output after
a second MPP+ perfusion. In the control-Ringer experiment, note that
the MPP+ on day 2 is the first MPP+ perfusion. Perfusion of FeCl3 (200
mu M) along with MPP+ (2.5 mM) and DES (100 mu M) on day 1 completely
abolished on day 2 the neuroprotective effect found with MPP+ (2.5 mM
) and DES (100 mu M). The ability of DES to protect against MPP+ toxic
ity may indicate a therapeutic strategy in the treatment of diseases w
hen iron is implicated. (C) 1997 Elsevier Science B.V.